Tag Archives: LIlly

Specialty Pharmacy News Roundup: March 2023

AMI’s Specialty Pharmacy Database continually monitors and tracks all limited and exclusive pharmacy distribution agreements

Walmart, Biologics and Avita Care Solutions Headline Recent Specialty Pharmacy Activities

Walmart, Biologics and Avita Care Solutions Headline Recent Specialty Pharmacy Activities to consolidate and strengthen and expand their pharmacy reach and drug contracts

Prescryptive Health Partners with Eli Lilly on Insulin Pricing

Prescryptive Health announced a partnership with Eli Lilly and Company on a subscription model to help lower costs for people who pay for their Lilly insulin through their employer-sponsored benefits

Express Scripts Divesting United Biosource

Express Scripts Divesting United Biosource. Express Scripts and Avista Capital Partners, a leading private equity firm, recently announced that Avista has signed a definitive agreement to acquire United BioSource (UBC), a wholly-owned subsidiary of Express Scripts Holding Company. Founded in 2003 and headquartered in Blue Bell, Pennsylvania, UBC is a leading provider of pharmaceutical and patient […]

John Santilli quoted in Modern Medicine: FDA approves Cyramza in combination with paclitaxel for advanced gastric cancer after prior chemotherapy

“Cyramza, approved earlier this year for stomach cancer, is a key product in Lilly’s oncology portfolio,” said John Santilli, of Access Market Intelligence, which provides market intelligence to the pharmaceutical and healthcare industries. “With the colorectal cancer market becoming increasingly crowded, Lilly will need to review the pricing strategy for Cyramza to make sure the drug remains competitive […]